Jim Wilson’s Gemma Biotherapeutics Enters into Partnership with the Abu Dhabi Department of Health and Purehealth to Advance Global Access to Gene Therapies for Rare Diseases

In its second international partnership, Gemma Biotherapeutics, co-founded by James M. Wilson, MD, PhD, the Rose H. Weiss Orphan Disease Center Director’s Professor in Penn Medicine, plans to establish manufacturing and research centers in Abu Dhabi and begin a gene therapy trial for spinal muscular atrophy. Read more here.